[1] T. L. Helle, R. H. Britt and T. V. Colby, “Primary Lymphoma of the Central Nervous System: Clinopathological Study of Experience at Stanford,” Journal of Neurosurgery, Vol. 60, No. 1, 1984, pp. 94-103. http://dx.doi.org/10.3171/jns.1984.60.1.0094
[2] F. H. Hochberg and D. C. Miller, “Primary Central Nervous System Lymphoma,” Journal of Neurosurgery, Vol. 68, No. 6, 1988, pp. 835-853. http://dx.doi.org/10.3171/jns.1988.68.6.0835
[3] N. L. Eby, S. Gufferman, C. M. Flannelly, S. C. Schold, F. S. Vogel and P. C. Burger, “Increasing Incidence of Primary Brain Lymphoma in the US,” Cancer, Vol. 62, No. 11, 1988, pp. 2461-2465. http://dx.doi.org/10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M
[4] F. J. Hans, M. H. Reinges, K. Nolte, P. Reipke and T. Krings, “Primary Lymphoma of the Skull Base,” Neuroradiology, Vol. 47, No. 7, 2005, pp. 539-542. http://dx.doi.org/10.1007/s00234-005-1394-4
[5] O. Dare, R. V. Datta, T. R. Loree, W. L. Hicks and W. Grand, “Sinonasal Non-Hodgkin’s Lymphoma with Skull Base Involvement,” Skull Base, Vol. 11, No. 2, 2001, pp. 129-135. http://dx.doi.org/10.1055/s-2001-14433
[6] S. Jung, M. Zimmermann and V. Seifert, “Clivus Lymphoma,” Acta Neurochirurgica, Vol. 146, No. 5, 2004, pp. 533-534. http://dx.doi.org/10.1007/s00701-004-0244-1
[7] S. M. Roman-Goldstein, A. Jones, J. B. Delashaw, S. Mc-Menomey and E. A. Neuwelt, “Atypical Central Nervous System Lymphoma at the Cranial Base: Report of Four Cases,” Neurosurgery, Vol. 43, No. 3, 1998, pp. 613-615. http://dx.doi.org/10.1097/00006123-199809000-00119
[8] K. Jaiswal, M. Tripathi, P. S. Chandra, M. C. Sharma and A. K. Maha-patra, “An Unusual Case of Primary Lymphoma of the Skull Base Extending from Cerebellopontine Angle to Cavernous Sinus and Orbit. A Case Report,” Journal Neurosurg Science, Vol. 44, No. 3, 2000, pp. 145-148.
[9] J. M. Henry, R. R. Heffner, S. H. Diiard, K. M. Earle and R. L. Davis, “Primary Malignant Lymphomas of the Central Nervous System,” Cancer, Vol. 34, No. 4, 1974, pp. 1293-1302.
http://dx.doi.org/10.1002/1097-0142(197410)34:4<1293::AIDCNCR2820340441>3.0.CO;2-P
[10] H. Oyama, M. Nagane, S. Shibui, K. Nomura and K. Mukai, “Skull Base Malignant Lymphoma: A Case Report and Review of the Literature,” Japanese Journal of Clinical Oncology, Vol. 22, No. 2, 1992, pp. 131-135.
[11] M. Shibata, M. Shimoda and O. Sato, “A Case of Bilateral Panopthalmoplegia Caused by Paranasal Malignant Lymphoma Extending into the Skull Base,” No Shinkei Geka, Vol. 20, No. 6, 1992, pp. 717-721.
[12] S. Tanaka, H. Nihei, S. Manaka and T. Hori, “A Case of Malignant Lymphoma in the Skull Base,” No Shinkei Geka, Vol. 22, No. 1, 1994, pp. 73-78.
[13] V. W. Tsai, L. Rybak, J. Espinosa, M. J. Kuhn, O. W. Kamel, F. Mathews and F. R. Glatz, “Primary B-Cell Lymphoma of the Clivus: Case Report,” Surgical Neurology, Vol. 58, No. 3-4, 2002, pp. 246-250. http://dx.doi.org/10.1016/S0090-3019(02)00845-5
[14] K. G. Davies, G. C. Cole and R. D. Weeks, “Twenty Year Survival Following Excision of Primary CNS Lymphoma without Radiation Therapy: Case Report,” British Journal of Neurosurgery, Vol. 8, No. 4, 1994, pp. 487-491. http://dx.doi.org/10.3109/02688699408995120
[15] W. Sonstein, K. Tabaddor and J. F. Ilena, “Solitary Primary CNS Lymphoma: Long Term Survival Following Total Re-section,” Medical Oncology, Vol. 15, No. 1, 1998, pp. 61-65.
http://dx.doi.org/10.1007/BF02787347
[16] S. A. Leibel and G. E. Sheline, “Radiation Therapy for Neoplasms of the Brain,” Journal of Neurosurgery, Vol. 66, No. 1, 1987, pp. 1-22. http://dx.doi.org/10.3171/jns.1987.66.1.0001
[17] D. F. Nelson, K. L. Martz, H. Bonner H, J. S. Nelson, J. Newall, H. D. Kerman, J. W. Thomson and K. J. Murray, “Non-Hodgkin’s Lymphoma of the Brain: Can High Dose, Large Volume Radiation Therapy Improve Survival? Report on a Prospective Trial by the Radiation Therapy Oncolgy Group (RTOG): RTOG 8315,” International Journal of Radiation Oncology, Biology, Physics, Vol. 23, No. 1, 1992, pp. 9-17. http://dx.doi.org/10.1016/0360-3016(92)90538-S
[18] J. Y. Blay, T. Conroy, C. Chevreau, A. Thyss, N. Quesnel, H. Eghbali, R. Bouabdallah, B. Coiffier, J. P. Wagner, A. Le Mevel, D. Dramais-Marcel, “High-Dose Methotrexate for the Treatment of Primary Cerebral Lymphomas: An Analysis of Survival and Late Neurological Toxicity in a Retrospective Series,” Journal of Clinical Oncology, Vol. 16, No. 3, 1998, pp. 864-871.
[19] M. Brada, D. Dearnaley, A. Horwich and H. J. G. Bloom, “Management of Primary Cerebral Lymphoma with Initial Chemotherapy: Preliminary Results and Comparison with Patients Treated with Radiotherapy Alone,” International Journal Radiation, Oncology, Biology, Physics, Vol. 18, No. 4, 1990, pp. 787-792. http://dx.doi.org/10.1016/0360-3016(90)90398-4
[20] L. M. DeAngelis, J. Yahalom, H. Thaler and U. Kher, “Combined Modality Therapy for Primary CNS Lymphoma,” Journal of Clinical Oncology, Vol. 10, No. 4, 1992, pp. 635-643.
[21] T. Banerjee, J. N. Mergher and W. E. Hunt, “Unusual Complications with use of Silastic Dural Substitute,” The American Surgeon, Vol. 40, No. 7, 1974, pp. 434-437.
[22] W. S. Fisher and E. G. Six, “Cervical Myelopathy from Dural Substitute,” Neurosurgery, Vol. 13, No. 6, 1983, pp. 715-716. http://dx.doi.org/10.1227/00006123-198312000-00020
[23] J. T. Keller, C. M. Ongkiko, M. C. Saunders, F. H. Mayfield and S. B. Dunsker, “Repair of Spinal Defects: An Experimental Study,” Journal of Neurosurgery, Vol. 60, No. 5, 1984, pp. 1022-1028.
http://dx.doi.org/10.3171/jns.1984.60.5.1022
[24] S. Robertson and A. Menezes, “Hemorrhagic Complications in Association with Silastic Dural Substitute: Pediatric and Adult Case Reports with a Review of the Literature,” Neurosurgery, Vol. 40, No. 1, 1997, pp. 201-206.
[25] E. E. Awwad, K. R. Smith Jr., D. S. Martin and A. Manepalli A, “Unusual Hemorrhage with Use of Synthetic Dural Substitute: MR findings,” Journal of Computer Assisted Tomography, Vol. 15, No. 4, 1991, pp. 618-620. http://dx.doi.org/10.1097/00004728-199107000-00017
[26] N. R. Berrington, “Acute Extradural Hematoma Associated with Silastic Dural Substitute: Case Report,” Surgical Neurology, Vol. 38, No. 6, 1992, pp. 469-470. http://dx.doi.org/10.1016/0090-3019(92)90117-6
[27] G. Gondo, S. Nakayama, Y. Mochimatsu, F. Nakajima and A. Hasegawa, “Posterior Fossa Hemorrhage 11 Years after the Use of Silastic Dural Substitute: Case Report,” No Shinkei Geka, Vol. 19, No. 1, 1991, pp. 59-62.
[28] D. Siccardi and A. Ventimiglia, “Fibrotic-Haemorrhagic Reaction to Synthetic Dural Substitute,” Acta Neurochirurgica, Vol. 132, No. 1-3, 1995, pp. 148-149. http://dx.doi.org/10.1007/BF01404864
[29] D. Simpson and A. Robson, “Recurrent Subarachnoid Bleeding in Association with Dural Substitute: Report of Three Cases,” Journal of Neurosurgery, Vol. 60, No. 2, 1984, pp. 408-409.
http://dx.doi.org/10.3171/jns.1984.60.2.0408
[30] N. Ohbayashi, T. Inagawa, Y. Katoh, K. Kumano, R. Nagasako and H. Hada, “Complication of Silastic Dural Substitute 20 Years after Dural Plasty,” Surgical Neurology, Vol. 41, No. 4, 1994, pp. 338-341. http://dx.doi.org/10.1016/0090-3019(94)90187-2
[31] R. Cohen, S. Aleksic and J. Ransohoff, “Inflammatory Reaction to Synthetic Dural Substitute: Case Report,” Journal of Neurosurgery, Vol. 70, No. 4, 1989, pp. 633-635.
http://dx.doi.org/10.3171/jns.1989.70.4.0633
[32] R. L. Friede and W. Schachenmayr, “The Origin of Subdural Neomembranes: II—Fine Structures of Neomembranes,” pp. 69-84.
[33] W. Schachenmayr and R. L. Friede, “The Origin of Subdural Neomembranes: I—Fine Structures of the Dura-arachnoid Interface in Man,” American Journal of Pathology, Vol. 92, No. 1, 1978, pp. 53-68.
[34] G. I. Schoefl, “Studies in Inflammation: III—Growing Capillaries: Their Structure and Permeability,” Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin, Vol. 337, No. 2, 1963, pp. 97-141. http://dx.doi.org/10.1007/BF00963592